ArticleFrontiers in immunology2022

A novel signature based on CeRNA and immune status predicts prognostic risk and drug sensitivity in gastric cancer patients.

Wei Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.